Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
PDE7A Blocking Peptide (AC1340)
Cat.#: ACPP-1340
Specifications
Despition PDE7A Blocking Peptide for Immunodepletion, Immunocompetition SIZE 250 µg Applications Immunodepletion & Immunocompetition assay Storage Store at -20⁰C for long term Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ACPP-1167 Recombinant Human CD133 Protein (Fc Tag) (AC1167) 50 µg inquiry ACPP-1130 Native Bovine GFAP Protein (AC1130) 25 µl inquiry ACPP-1535 Human VAMP8 Protein (AC1535) 5 µg inquiry ACPP-1748 Human PAFAH1B3 Protein (AC1748) 5 µg inquiry ACPP-1120 Human NRG1 Protein (AC1120) 10 µg inquiry ACPP-1831 Human STOM Protein (AC1831) 5 µg inquiry ACPP-1326 Galectin 3 Blocking Peptide (AC1326) 250 µg inquiry ACPP-1720 Human PNPO Protein (AC1720) 5 µg inquiry ACPP-1190 ADCY6 Blocking Peptide (AC1190) 250 µg inquiry ACPP-1031 Recombinant Human CD24 Protein (Fc Tag) (AC1031) 50 µg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket